The Permeability of the Endoplasmic Reticulum Is Dynamically Coupled to Protein Synthesis by Roy, Anirban & Wonderlin, William F.
Faculty Scholarship
2003
The Permeability of the Endoplasmic Reticulum Is
Dynamically Coupled to Protein Synthesis
Anirban Roy
William F. Wonderlin
Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications
This Article is brought to you for free and open access by The Research Repository @ WVU. It has been accepted for inclusion in Faculty Scholarship
by an authorized administrator of The Research Repository @ WVU. For more information, please contact ian.harmon@mail.wvu.edu.
Digital Commons Citation
Roy, Anirban and Wonderlin, William F., "The Permeability of the Endoplasmic Reticulum Is Dynamically Coupled to Protein
Synthesis" (2003). Faculty Scholarship. 378.
https://researchrepository.wvu.edu/faculty_publications/378
The Permeability of the Endoplasmic Reticulum Is
Dynamically Coupled to Protein Synthesis*
Received for publication, July 19, 2002, and in revised form, November 21, 2002
Published, JBC Papers in Press, November 27, 2002, DOI 10.1074/jbc.M207295200
Anirban Roy and William F. Wonderlin‡
From the Department of Biochemistry and Molecular Pharmacology, Robert C. Byrd Health Sciences Center,
West Virginia University, Morgantown, West Virginia 26506
Proteins synthesized by the rough endoplasmic retic-
ulum (RER) co-translationally cross the membrane
through the pore of a ribosome-bound translocon (RBT)
complex. Although this pore is also permeable to small
molecules, it is generally thought that barriers to their
permeation prevent the cyclical process of protein
translation from affecting the permeability of the RER.
We tested this hypothesis by culturing Chinese hamster
ovary-S cells with inhibitors of protein translation that
affect the occupancy of RBTs by nascent proteins and
then permeabilizing the plasma membrane and meas-
uring the permeability of the RER to a small mole-
cule, 4-methyl-umbelliferyl--D-glucopyranoside (4-
MG). The premature or normal release of nascent pro-
teins by puromycin or pactamycin, respectively, in-
creased the permeability of the RER to 4-MG by 20–
30%. In contrast, inhibition of elongation and the release
of nascent proteins by cycloheximide did not increase
the permeability, but it prevented the increase in per-
meability by pactamycin. We conclude that the perme-
ability of the RER is coupled to protein translation by a
simple gating mechanism whereby a nascent protein
blocks the pore of a RBT during translation, but after
release of the nascent protein the pore is permeable to
small molecules as long as an empty ribosome remains
bound to the translocon.
In eukaryotes, secretory and most integral membrane pro-
teins are synthesized by a translationally active 80 S ribosome
composed of 60 S and 40 S subunits and bound to a translocon
complex, a heteromeric assembly of proteins embedded in the
membrane of the rough endoplasmic reticulum (RER)1 (Fig. 1).
Nascent proteins emerging from the exit tunnel of the 60 S
subunit co-translationally cross the membrane of the RER by
passing through a protein-conducting channel (PCC) in the
translocon complex (1). The exit tunnel of the 60 S subunit and
the pore of the PCC must be large enough to be permeated by
a nascent protein chain, and this pathway is therefore large
enough to be permeated by many other small molecules when a
ribosome-bound translocon (RBT) is translationally inactive
and empty, i.e. the pore is not occupied by a nascent protein.
We previously demonstrated (2) that the permeability of RBTs
to a small, polar molecule (4-methyl-umbelliferyl--D-glucopy-
ranoside (4-MG)) was increased after puromycin, a tRNA
analog, prematurely terminated translation and released nas-
cent protein chains from the PCC (path a, Fig 1). The increased
permeability to 4-MG was consistent with a previous report
that RBTs incorporated into planar bilayers and opened by
puromycin are permeable to ions (3), and our results were also
supported by a recent report that puromycin can release cal-
cium from the RER (4). The permeation of empty RBTs is
especially significant in the context of recent studies by
Nicchitta and colleagues (5, 6), who reported that approxi-
mately two-thirds of the 60 S subunits remain bound to trans-
locons after the normal completion of protein translation,
thereby constituting a large pool of persistent, translationally
inactive RBT complexes. Although permeation of these empty
RBTs could have very important consequences for RER-de-
pendent signaling and the maintenance of essential gradients
across the RER membrane, this pathway has received rela-
tively little attention.
The permeation of translocons by small molecules has also
been investigated by Johnson and colleagues (7, 8), who con-
cluded that a permeability barrier is maintained at the luminal
end of the translocon by the binding of BiP, a luminal chaper-
one protein, and that the junction between the 60 S subunit
and the translocon is tightly sealed. Their conclusions have led
to the broadly held view that RBTs are tightly sealed at all
times, preventing the process of protein translation from influ-
encing the permeability of the RER to small molecules. We
propose, however, that the notion that the permeability of the
RER is not affected by permeation of RBTs might be limited to
experimental conditions in which translationally inactive,
empty ribosomes have been stripped from ER microsomes by a
high-salt wash. This experimental detail is important because
it limits the detection of permeation to only two states of the
translocon, the translationally active 80 S-bound translocon
and the ribosome-free translocon (blocked and closed states,
respectively, in Fig. 1). A novel feature of our current study is
that we have used experimental conditions in which perme-
ation of a third state of the translocon, translationally inactive
60 S-bound RBTs, can also be detected.
In this article we examine two models that describe the
relationship between the translational activity of RBTs and the
permeability of the RER to a small molecule, 4-MG. The first
model is a “static permeability” model in which RBTs are never
permeable to small molecules other than nascent proteins, and
the permeability of the RER is therefore independent of trans-
lational activity. The second model is a “dynamic permeability”
model in which the pore of an RBT is “gated” closed when it is
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occupied by a nascent protein, but the pore of translationally
inactive, 60 S-bound translocons is open and permeable to
small molecules. This simple physical mechanism for coupling
the permeability of the RER to protein translation predicts a
dynamic relationship in which increasing the level of protein
translation and the occupancy of RBTs by nascent proteins
should decrease the permeability of the RER, whereas inhibit-
ing the initiation of protein translation and decreasing the
occupancy of RBTs by nascent proteins should increase the
permeability of the RER.
The appropriateness of the static versus dynamic permeabil-
ity models can be tested by determining the extent to which the
permeability of the RER is dependent on the level of protein
translation and the occupancy of RBTs by nascent proteins.
The static permeability model predicts complete independence,
whereas the dynamic permeability model predicts that the
permeability of the RER is inversely related to the level of
occupancy by nascent proteins during protein translation. The
goal of the current study was to test these predictions by
measuring the permeability of the RER to 4-MG while ma-
nipulating protein translation with drugs that inhibit protein
translation by different mechanisms of action. Puromycin
(PUR) resembles aminoacyl-tRNA, and it is a substrate for the
peptidyltransferase of the 60S subunit, accepting a nascent
peptide and causing the premature release of incomplete nas-
cent proteins (9). Pactamycin (PAC) inhibits the initiation of
protein translation by preventing formation of the 43S initia-
tion complex, but it permits the normal elongation and release
of full-length proteins whose synthesis was initiated prior to
addition of the drug (10, 11). Cycloheximide blocks elongation
and prevents the normal completion and release of nascent
proteins from RBTs (12). Cycloheximide stabilizes polyribo-
somes and the association of 80S ribosomes with translocons,
whereas PUR and PAC elicit rapid breakdown of polyribo-
somes, but leave the majority of translationally inactive 60S
subunits bound to the RER (5). We report that the permeability
of the RER was sensitive to the manipulation of protein trans-
lation and changes in the occupancy of RBTs by nascent pro-
teins, and we conclude that the permeability of the RER is
dynamically coupled to protein translation.
EXPERIMENTAL PROCEDURES
Materials—4-MG, cycloheximide, and puromycin-HCl were from
Calbiochem. Pactamycin was a generous gift from The Upjohn Co. All
other reagents were from Sigma.
Cell Culture—CHO-S cells (Invitrogen), a cell line derived from Chi-
nese hamster ovary K1 cells and selected for growth in suspension, was
used for most experiments. A cell line derived from HEK-293 cells for
growth in suspension (HEK-293-F) was also obtained from Invitrogen.
HepG2 and BHK-21 cells were obtained from the ATCC (Manassas,
VA). CHO-K1 cells were a gift from Ed Levitan (University of
Pittsburgh). CHO-S and HEK-293-F cells were grown in serum-free
medium (CHO-SFII and 293SFII medium, respectively, from Invitro-
gen). CHO-K1 cells were grown in Ham’s F12 medium containing 5%
serum, and BHK-21 and HepG2 cells were grown in Dulbecco’s modified
Eagle’s medium containing 10% serum. All cells were cultured at 37 °C,
8% CO2.
4MG Assay—The 4-MG assay was performed as described by
Heritage and Wonderlin (2). Briefly, CHO-S cells and HEK-293-F cells
were typically grown to a density of 0.5–1.0 106 cells/ml in T-75 flasks
or in spinner flasks. For a 32-well assay (eight conditions in quadrupli-
cate), 20 ml of cells was pelleted and resuspended in 20 ml of K-G buffer
(140 mM potassium glutamate, 2.5 mM MgCl2, 10 mM HEPES, pH 7.25)
and gently permeabilized by N2 cavitation (2 min, 80 p.s.i.). This pro-
cedure was modified for adherent cells. BHK-21 and CHO-K1 cells were
grown in T-75 flasks, harvested by scraping, and then homogenized in
K-G buffer by N2 cavitation. HepG2 cells were grown to confluence in
48-well plates, and the medium was replaced with K-G buffer contain-
ing 0.08% digitonin (100 l/well) for 5 min to permeabilize the cells and
then diluted 1:5 with K-G buffer. Nunc 48-well plates were loaded with
0.5 ml of sample/well, the plate with solutions was prewarmed to 35 °C,
and 4-MG (20 M from a 20 mM stock in methanol) was added imme-
diately before placing the plate into a CytoFluor 4000 plate reader. The
fluorescence was measured for 30 min at 2-min intervals with 10 s
mixing before each measurement. The center wavelengths/bandwidths
of the excitation and emission filters were 360/40 and 460/40,
respectively.
Data Analysis—In CHO-S cells, 4-MG is activated when it enters
the lumen of the RER and it is hydrolyzed by -glucosidase II. The slope
of the fluorescence versus time curve, S(t), is proportional to the rate of
entry and activation of the dye at time t. The linear and exponential
contributions to S(t) were fitted by Equation 1,
St S0  ekt (Eq. 1)
where S0 is the initial slope (F min
1) and k is an exponential rate
constant (min1). Best-fit estimates of S0 and k for each well were
obtained using the Solver nonlinear curve-fitting routine in Excel (Mi-
crosoft). All experimental conditions were assayed in parallel  deter-
gent (0.05% Igepal, Fig. 2A) so that the permeability to 4-MG under a
specific experimental condition could be expressed as a dimensionless
fractional permeability (P),
P S0/S0,max (Eq. 2)
where S0,max is the rate of activation after the RER membrane was
permeabilized by detergent and the access of 4-MG to the -glucosi-
dase II was maximal. Statistical analysis was performed using JMPin
(SAS Institute). Averages are plotted  standard error of the mean.
Calcium Measurements—CHO-S cells were loaded with 10 M Fluo-
3-AM (30 min, 23 °C) and then washed twice in Hanks’ balanced salt
solution. Fluorescence emission at 510 nm was measured with excita-
tion at 485 nm in a CytoFluor 4000 plate reader. Adherent BHK-21 cells
grown in 10% Dulbecco’s modified Eagle’s medium (8% CO2, 37 °C) were
released by trypsinization and gentle trituration and then loaded with
10 M Mag-Fura-2-AM (60 min, 37 °C) in Dulbecco’s modified Eagle’s
medium minus serum. The cells were washed twice in Hanks’ balanced
salt solution and loaded into a stirred cuvette in a SPEX Fluorolog
spectrometer. The ratio of fluorescence measured at 510 nm with exci-
tation alternating between 340 and 380 nm was calculated at each time
point without further calibration.
RESULTS
Rationale for Testing the Permeability Models—We have
studied the permeation of RBTs in CHO-S cells by 4-methyl-
umbelliferyl--D-glucopyranoside (4-MG), a small, mem-
brane-impermeant probe; it’s entry into the RER can be de-
tected when it is hydrolyzed to a fluorescent product by luminal
-glucosidase II. We previously reported (2) that the activation
of 4-MG in intact CHO-S cells was negligible, but the selective
rupture of the plasma membrane by N2 cavitation enabled
4-MG to access the RER, and it revealed a substantial basal
permeability of the RER to 4-MG (Pbasal). This permeability
was further increased to a level termed PPUR when nascent
FIG. 1. Permeation of ribosome-bound translocons. Following
the completion of translation, either the 80 S ribosome (path d) or the
40 S subunit (path a) can be released from the PCC (dark gray). Only
the translationally inactive, 60 S-bound state of the PCC is permeable
to 4-MG. The pathway is blocked by a nascent protein in the 80
S-bound state and closed in the ribosome-free state (2). PUR and PAC,
but not CHX, shift the majority of 80 S-bound translocons to the empty,
60 S-bound state (5) (path a). The 60 S subunit can be released by high
salt (path c), thereby closing the pore (2).
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chains were released by the addition of PUR (Fig. 2).
The static permeability model predicts that Pbasal should be
insensitive to changes in the occupancy of RBTs by nascent
proteins produced by concomitant changes in protein transla-
tion. This model was tested using a two-step procedure. In the
first step, cells were pretreated in culture with PUR, PAC, or
CHX to produce changes in the occupancy of RBTs. In the
second step, these cells were permeabilized, split into two sam-
ples, and P was determined in each sample either without PUR
(Pbasal) or with PUR (PPUR) added to the sample, respectively.
The occupancy of translationally active RBTs by nascent pro-
teins after the pretreatment period was estimated by calculat-
ing the PUR-dependent increase in P,
PPUR PPUR Pbasal (Eq. 3)
where PPUR is proportional to the number of blocked, trans-
lationally active RBTs that could be opened by PUR added
during the assay. If pretreatments that decreased the occu-
pancy of RBTs by nascent proteins (as inferred from a signifi-
cant decrease in PPUR) also significantly increased Pbasal, the
static model should be rejected.
Given the importance of Pbasal and PPUR in these tests, we
first examined in greater detail three features of Pbasal and
PPUR in this system: (1) the similarity of Pbasal and PPUR
measured in CHO-S cells to other cell lines, (2) the specificity of
PPUR as a measure of the occupancy of translationally active
RBTs by nascent chains, and (3) the contribution of RBT-
mediated permeation to Pbasal.
Similarities in Permeability (P) among Different Cell
Lines—We examined the activation of 4-MG in the absence
and presence of PUR in CHO-S, CHO-K1, HEK-293-F, BHK-
21, and HepG2 cells. We observed in all of these cell lines a
substantial Pbasal and a similar 30–40% increase in P when
puromycin was added to the assay (Fig. 2B). The similarity
between CHO-S and HepG2 cells is especially notable, because
Seiser and Nicchitta (5) reported that approximately two-
thirds of the ribosomes remain bound to the RER membrane in
HepG2 cells following either the premature termination of
translation by PUR or the normal completion of translation
with pactamycin. We conclude from these similarities that the
mechanisms that regulate the permeation of RBTs are proba-
bly also similar among these cell lines and that the high Pbasal
and the PPUR are not unusual features of CHO-S cells. These
results support our use of CHO-S cells in the present study as
a model system for investigating the permeability of the RER.
PPUR Is a Measure of the Pool of Translationally Active
RBTs—We previously concluded (2) that PPUR was produced
by the release of nascent chains from translationally active
RBTs on the basis of the generally recognized mechanism of
action of puromycin as a tRNA analog (9), the similar sensitiv-
ity to high salt of PPUR and the binding of ribosomes to ER
membranes (13), and the absence of PPUR in the presence of
detergent, which demonstrated that PPUR required the entry
of 4-MG into a membrane-bound compartment. In the current
study we wanted to use the size of PPUR to track changes in
the size of the pool of translationally active RBTs (i.e. those
RBTs occupied by nascent proteins that could be released by
PUR) in response to treatments with inhibitors of protein syn-
thesis. The puromycin reaction catalyzed by the peptidyltrans-
ferase is essential for the release of nascent proteins, and we
performed the following additional experiments to provide a
more rigorous test of the specific dependence of PPUR on the
puromycin reaction.
Anisomycin is an inhibitor of the peptidyltransferase and the
puromycin reaction (14). When added simultaneously with
PUR, 50 M anisomycin completely inhibited PPUR, but it did
not inhibit PPUR when it was added 10 min after PUR, suffi-
cient time for the irreversible release of nascent chains by PUR
(Fig. 3A). The failure of anisomycin to significantly inhibit
PPUR when added after PUR demonstrated that the ability of
anisomycin to inhibit PPUR when applied with PUR did not
result from nonspecific effects, such as blocking the pore of
empty RBTs. We conclude from the complete inhibition of
PPUR when anisomycin was applied with PUR that the pro-
duction of PPUR required an anisomycin-sensitive peptidyl-
transferase reaction.
The puromycin reaction is maximum at pH 8.5–9.5, with a
pKa of 7.2–7.6 and a steep decrease in rate at neutral pH and
below (15, 16). We observed that PPUR was inhibited when the
buffer was acidified from pH 7.2 to pH 6.6 before the addition
of PUR, but acidification to pH 6.6 15 min after the addition of
PUR had no effect (Fig. 3B). The temporal dependence of the
inhibition by low pH leads us to conclude, again, that the
inhibitory effect was on the puromycin reaction and not the
permeability pathway.
We conclude that the production of PPUR is entirely depend-
ent on the puromycin reaction catalyzed by the peptidyltrans-
ferase center, and it is therefore a valid measure of the release
of nascent proteins from translationally active RBTs. The
measurement of PPUR provides an alternative approach for
FIG. 2. Pbasal and PPUR are similar in different cell lines. A,
example of a permeabilized cell assay showing increasing fluorescence
of 4-MG versus duration of incubation. Lines are best fits (see Equa-
tion 1) to the fluorescence measured without detergent (squares) or with
detergent (0.05% Igepal, circles). The addition of 100 M PUR (black)
increased the slope (S0) relative to control (gray) in the absence but not
the presence of detergent. B, average Pbasal (gray) and PPUR (black)
values for five cell lines. The greater variability of the averages in
CHO-K1 and BHK21 cells probably resulted from the more difficult and
less consistent permeabilization of these adherent cells, which in-
creased the inter-assay variability in the base-line permeability. In
contrast, the ratio PPUR/Pbasal was much more consistent across assays.
Therefore, we tested the hypothesis that puromycin increased P by
examining the ratio PPUR/Pbasal, which was significantly greater than a
value of 1 for all cell lines (p  0.05, multiple t tests with Bonferroni
adjustment).
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determining the size of the pool of translationally active RBTs
that is much simpler than other methods (e.g. radiolabeling
nascent proteins). It is also insensitive to translationally active
ribosomes in the cytosol, because only the release of nascent
proteins from translationally active ribosomes that are bound
to the RER can increase the activation of 4-MG. Although
PPUR provides only a relative measure of the translational
activity of RBTs, that was sufficient for our current study in
which we wanted to use PPUR to track changes in the size of
the pool of translationally active RBTs in response to inhibitors
of protein synthesis.
The Contribution of RBTs to Pbasal —We have observed over
a 2-year period that Pbasal can slowly change in CHO-S cells
over the course of several weeks or months, with Pbasal ranging
from 0.2 to 0.7. This variability led us to speculate that the
entry of 4-MG via pathways other than RBTs might contrib-
ute a labile background component to Pbasal and cause us to
underestimate the importance of changes in Pbasal mediated
specifically by permeation of RBTs. In the absence of drugs that
can specifically inhibit the permeation of RBTs, we have esti-
mated the component of Pbasal contributed by the permeation of
RBTs, relative to the background permeability contributed by
other, unidentified pathways, by examining the sensitivity of
Pbasal to high salt, which has been reported to release up to 85%
of the translationally inactive ribosomes from the RER mem-
brane in rat hepatocytes (path c, Fig. 1) (13). Although high salt
might also inhibit RBT-independent pathways for the entry of
4-MG, we have demonstrated previously (2) that both the
concentration of salt producing half-maximal block and the
slope of the salt concentration-inhibition curve were identical
for PPUR and the salt-sensitive component of Pbasal. We sur-
mised from the remarkably similar sensitivities to high salt
that both salt-sensitive components were produced by the entry
of 4-MG through a common pathway. Cells were split into two
samples, with one sample broken open in high-salt (300 mM K)
K-G buffer and the other sample broken open in normal (140
mM K) K-G buffer. A plot of Pbasal measured in high-salt versus
normal buffer is shown in Fig. 3C. The dotted line with unity
slope indicates the relationship expected if Pbasal was not af-
fected by high salt, and it is clear that Pbasal measured in high
salt was depressed relative to Pbasal measured in normal salt,
consistent with our previous report that Pbasal was sensitive to
high salt (2). Most importantly, a regression line fitted to these
data had a slope of 0.94 (0.10), insignificantly different from
a value of 1. We conclude from the parallel downward shift of
the relationship that Pbasal was decreased on average by 0.2
in high-salt relative to normal-salt buffers regardless of the
size of Pbasal in normal salt. The data in Fig. 3C also indicate
that the apparent lower limit of Pbasal is 0.2, from which we can
conclude that in some samples of cells 4-MG enters the RER
exclusively through empty RBTs. These data indicate that the
size of the salt-sensitive permeability to 4-MG was surpris-
ingly constant compared with the high variability of the salt-
insensitive component.
Effect of Puromycin—The primary test of the static perme-
ability model was to determine whether pretreating cells with
PUR prior to permeabilization could reversibly increase Pbasal.
CHO-S cells were pretreated with 200 M PUR for 15 min to
terminate translation and release nascent proteins from RBTs,
after which half of the cells were permeabilized and assayed.
Pretreatment with PUR significantly increased Pbasal while
substantially reducing PPUR (Fig. 4A), as expected if all of the
available nascent proteins were released from translationally
active RBTs during the pretreatment period. If the increase in
Pbasal resulted from the release of nascent proteins and the
opening of RBTs, it should be reversed by restarting transla-
tion and increasing the occupancy of RBTs by nascent proteins.
The remaining control and PUR-treated cells were pelleted,
washed, and transferred to control medium for 30 min, at
which time Pbasal was not significantly different from the con-
trol level (Fig. 4A), demonstrating that restarting protein syn-
thesis could reverse the increase in Pbasal.
Effect of Pactamycin—To ensure that the increase in Pbasal
produced by PUR was not an artifact of the premature release
of truncated proteins by PUR, we also examined pactamycin,
which should release full-length proteins. A 1-h pretreatment
with PAC significantly increased Pbasal and eliminated PPUR
FIG. 3. A, inhibition of PPUR by anisomycin. 50 M anisomycin was
added either simultaneously with 100 M PUR (left pair of bars, n 	 5)
or 10 min after the addition of 100 M PUR (right pair of bars, n 	 6).
When added with PUR, anisomycin significantly decreased PPUR (p 
0.01, t test, asterisk) relative to the control. B, inhibition of PPUR by
acidification. A sample of cells was permeabilized in K-G buffer acidi-
fied with glacial acetic acid to pH 6.6, and 100 M PUR was then added
to half of the sample (left pair of bars, n 	 6). A second sample of cells
was permeabilized in normal K-G buffer (pH 7.2), and 100 M PUR was
added to half of the sample. After 15 min, concentrated glacial acetic
acid was added to lower the pH to 6.6. (right pair of bars, n 	 2). Gray
and black bars represent Pbasal and PPUR, respectively. PPUR was inhib-
ited only when acidification occurred prior to the addition of PUR (p 
0.05, t test, asterisk) C, plot of Pbasal measured in paired samples of
CHO-S cells broken open in either 140 K-G buffer (abscissa) or 300 K-G
buffer (ordinate). The dotted line has a slope of unity, and the solid line
is a line fitted by linear regression (slope	 0.94, intercept	0.16, n	
26). The slope of the fitted line was not significantly different from the
slope of the dotted line. These data were collected over a 2-year period.
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(Fig. 4B), as observed with PUR pretreatment. Similar, signif-
icant increases in Pbasal were observed following pretreatments
with PAC for 5, 30, 60, or 360 min, indicating that the increase
in Pbasal was both rapid and sustained (data not shown).
The increase in Pbasal was eliminated when control and PAC-
treated cells were permeabilized in a buffer in which the po-
tassium glutamate concentration was increased to 300 mM (Fig.
4B), which supports a role for empty RBTs because translation-
ally inactive ribosomes can be stripped from the RER by a
high-salt buffer (13). Also, unlike PUR, the acute application of
PAC to permeabilized control cells did not increase Pbasal (data
not shown), which is consistent with the ability of PUR to
release nascent proteins directly versus the PAC requirement
that synthesis be completed and nascent proteins be released
prior to permeabilization.
The similar increase in Pbasal produced by pretreating intact
cells with either PAC or PUR can be accounted for by the
conversion of blocked RBTs to open RBTs. The increase in
Pbasal was balanced entirely by the loss of PPUR, resulting in
no net increase in PPUR (Fig. 4, A and B), which was expected
if the increase in Pbasal depended solely on the conversion of
blocked RBTs to open RBTs along path a in Fig. 1. Also, the
increase in Pbasal produced by both PUR and PAC was about
70% of the PPUR measured in control cells (Fig. 4, A and B,
where PPUR reflects the size of the translationally active pool
in control cells), which was remarkably consistent with the
previous report of a persistent binding of 65% of 60 S sub-
units after the release of nascent proteins (5).
Effect of Cycloheximide—In contrast to PUR and PAC, a 1-h
pretreatment with 200 M cycloheximide (CHX) did not in-
crease Pbasal (Fig. 4C). A similar lack of effect was observed
with 5- or 360-min pretreatments (data not shown), indicating
that the different effects of PAC and CHX were not limited to a
specific point in time. The failure of CHX to increase Pbasal
demonstrated that the increased Pbasal produced by PUR or
PAC was not a nonspecific consequence of inhibiting protein
translation (e.g. clearing of proteins from the lumen of the
RER). The fact that PAC, but not PUR, requires elongation for
the release of nascent chains led us to predict that CHX would
prevent the increase in Pbasal by PAC, but CHX should have
much less of an effect on the increase in Pbasal by PUR. Co-
treatment with CHX completely prevented PAC from increas-
ing Pbasal (Fig. 4C), whereas CHX decreased PPUR by only
20–30% (data not shown).
PUR-dependent Release of Calcium in Intact Cells—We also
examined changes in the permeability of the ER to Ca2
 to
determine whether changes in the permeability to 4-MG could
be generalized to Ca2
 and as a control to ensure that changes
in the permeability of the ER could be observed in intact cells
in which no cytosolic constituents that might regulate the
permeability of RBTs could be lost, in contrast to the 4-MG
assay that requires permeabilization of the plasma membrane
for the entry of 4-MG. Intact CHO-S cells were loaded with
the Ca2
 indicator Fluo-3 and treated in parallel with PUR and
thapsigargin (TG), a selective inhibitor of the Ca-ATPase in the
ER (17), with the response to TG providing a positive control for
a Ca2
 signal produced by the release of Ca2
 from the ER.
Thapsigargin (100 nM) and PUR produced similar, triphasic
changes in [Ca2
] (Fig. 5, A and B), both beginning with a
transient increase. The increase in [Ca2
] elicited by PUR was
not a nonspecific effect of inhibiting protein synthesis, because
it was observed in cells in which protein synthesis was already
inhibited by pretreatment with CHX (Fig. 5A). We also used
Mag-Fura-2 to monitor more specifically changes in the perme-
ability to Ca2
. BHK-21 cells were loaded with Mag-Fura-2
under conditions in which the [Ca2
] in the lumen of the ER
could be preferentially monitored (18). Although we could not
detect changes in luminal [Ca2
] with the addition of PUR to
intact BHK-21 cells (data not shown), PUR significantly in-
creased the rate of release of Ca2
 from the ER in intact cells
when re-uptake was inhibited by TG (Fig. 5C), evidence that
the permeability to Ca2
 was increased. Our observation that
PUR increased the permeability of the RER to calcium in intact
cells is consistent with a recent report that PUR depleted
calcium in the RER of dialyzed or permeabilized cells (4), and
our observations in intact cells demonstrated that the changes
in the permeability to 4-MG produced by PUR did not result
from the loss of potential regulatory factors following perme-
abilization of the plasma membrane.
DISCUSSION
We conclude from the experiments reported above that the
permeability of the RER can be dynamically coupled to the
level of protein translation by changes in the number of empty
(i.e. open) versus blocked RBTs. Dynamic coupling could be
produced by a simple mechanism requiring only the following
features: (1) the pore of the PCC and the exit tunnel of the 60
S subunit are blocked by a nascent protein when the RBT is
FIG. 4. Pretreatment with PUR, PAC, and CHX differentially
affects P. Gray and black bars represent Pbasal and PPUR, respectively.
Asterisks indicate a significant (p  0.05, Dunnet’s test) increase in
Pbasal relative to the control Pbasal, which is also marked by a dotted line.
A, pretreatment with PUR reversibly increased Pbasal and reduced
PPUR. Identical assays were performed with cells incubated in 200 M
PUR for 15 min (left set of bars) or following a 30-min washout (right set
of bars) (n 	 6). B, a 1-h incubation of CHO-S cells in 200 nM PAC
increased Pbasal and eliminated PPUR when cells were broken open in
140 mM K-G buffer (left set of bars, n 	 7), but the increase in Pbasal was
absent when cells were broken open in 300 mM K-G buffer (right set of
bars, n 	 4). C, a 1-h incubation in 50 M CHX did not increase Pbasal
(left set of bars, n 	 5), in contrast to the significant increase produced
by PAC. When PAC and CHX were combined (right set of bars, n 	 4),
the inhibitory effect of CHX was dominant.
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translationally active; (2) following the normal completion of
translation and the release of a nascent protein, some empty
ribosomes remain persistently bound to translocons; (3) the
pore of empty RBTs is permeable to small molecules; and (4)
the relative distribution of blocked versus empty translocons is
influenced by the level of protein translation. The apparent
high barrier to the permeation of translocons by small mole-
cules, as described by Johnson and colleagues (Ref. 7; also
reviewed in Ref. 8), is probably limited to experimental condi-
tions in which permeable, translationally inactive ribosomes
have been stripped from translocons by high salt, leaving only
impermeable, translationally active RBTs and closed, ribo-
some-free translocons. This conclusion is supported by our cur-
rent and previous observation (2) that Pbasal was significantly
lower when measured in a high-salt buffer, presumably a result
of the dissociation of ribosomes from translationally inactive
RBTs.
At a macroscopic level, the functional consequences of the
dynamic coupling between Pbasal and protein translation de-
pend on the dynamic range over which Pbasal can vary, and we
expect that this range will be affected by the properties of
different permeant molecules. For 4-MG, the release of all of
the nascent chains by PUR or PAC increased Pbasal by 30%
(we have not yet examined the level to which Pbasal can be
decreased by increasing translational activity and converting
empty RBTs to blocked RBTs). However, the presence of both
salt-sensitive and salt-insensitive components of Pbasal meas-
ured with 4-MG provided evidence that it could enter the RER
through one or more channels or carriers in addition to empty
RBTs, which was not surprising given the small size and sim-
ple structure of 4-MG. The increased background permeabil-
ity resulting from the permeation of more than one pathway by
4-MG reduced the apparent size of the increase in Pbasal that
was produced by the release of nascent proteins. For larger
molecules that can enter the RER by permeating empty RBTs
but not via smaller channels or carriers, the dynamic range
could be significantly larger.
The dynamic coupling between Pbasal and protein translation
appears to occur in addition to a substantial contribution of
empty RBTs to the steady-state permeability of the RER. We
measured the salt-sensitive component of Pbasal, which in-
cludes, but is not necessarily limited to, the entry of 4-MG
through empty RBTs. From these measurements we estimated
that permeation of salt-sensitive, empty RBTs in the absence of
puromycin consistently contributed a fractional permeability to
4-MG of 0.2 regardless of the size of Pbasal (Fig. 3C). Given an
average size of PPUR of 0.10 (2), we estimate that the ratio of
empty to occupied RBTs might be as high as 2:1. This ratio is
considerably higher than expected based on ultrastructural
studies in which most ribosomes appear to be part of transla-
tionally active polysomes (e.g. Fig. 174 in Ref. 20). However,
our results are more consistent with a study by Adelman et al.
(13) in which 40% of the ribosomes could be released from rat
liver microsomes with salt alone, and an additional 40–45%
could be released with the combination of high salt and puro-
mycin. These authors concluded that the ribosomes released by
high salt in the absence of puromycin were mostly translation-
ally inactive, empty ribosomes, and their results would support
a ratio of empty to occupied RBTs of 1:1. Our results are also
consistent with a high permeability to small solutes observed in
rough microsomes prepared from rat liver without treatment
with high salt (19). Resolution of this issue will require parallel
measurements of permeability and ultrastructure in the same
cells.
A high resting permeability to small molecules mediated by
empty RBTs also raises the question as to how the RER might
maintain essential gradients across its membrane or different
environments (e.g. oxidizing versus reducing) in the lumen
versus the cytosol. Although the Ca-ATPase in the ER mem-
brane could maintain a calcium gradient in the presence of a
leak pathway, it is less clear which transporters might main-
tain gradients for other molecules of interest. Of course, any
speculation as to the potential effect of empty RBTs on the
permeability of the RER to small molecules must be tempered
by the fact that thus far we have only demonstrated perme-
ation by 4-MG and calcium, and further study will be required
to determine the repertoire of small molecules that can perme-
ate empty RBTs.
The macroscopic changes in Pbasal described above might be
especially important during global changes in protein transla-
tion, such as when the initiation of protein synthesis is inhib-
ited in response to cellular stress (21). In this context, the
increase in Pbasal produced by PAC provides a new clue into the
mechanism of stress-induced apoptosis. Many cytosolic and ER
stressors inhibit the initiation of protein translation by activat-
ing the phosphorylation of the translation initiation factor
eIF-2 (21), an effect mimicked by PAC. If inhibiting the initi-
ation of translation increases the permeability of the RER, as
we observed with PAC, then RER-dependent homeostatic pro-
cesses might be disrupted, thereby promoting apoptosis. The
FIG. 5. PUR increased the permeability to calcium. A, CHO-S
cells were loaded with Fluo-3, and PUR or TG (100 nM) was added at
time zero. A single representative experiment is shown with cells pre-
treated for 30 min with 50 M CHX to inhibit protein synthesis prior to
the addition of PUR. B, averaged responses in five experiments per-
formed as described in A and plotted with standard error bars. For TG,
the latency to the decline from the peak to the nadir was highly vari-
able. C, decay of ER luminal Ca2
 in BHK-21 cells loaded with Mag-
Fura-2. 100 nM TG alone or TG and 200 M PUR were added at time
zero. The decay of luminal [Ca2
] was fitted with a single exponential
function and plotted with the fitted line on a semi-log plot. The inset
shows a significant decrease (p  0.05, t test, n 	 6) in the average time
constant for the decay with PUR (black) and without PUR (gray).
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ability of cycloheximide to stabilize nascent chains within
RBTs and prevent PAC from increasing Pbasal might explain
why CHX can also prevent stress-induced apoptosis under con-
ditions in which protein synthesis is already inhibited, such as
during ischemia/reperfusion (22); and the opposing actions of
CHX and PUR on Pbasal might account for the paradoxical,
pro-apoptotic effects of PUR in situations where CHX is pro-
tective (23, 24). From a methodological perspective, experimen-
tal manipulations that stress cells and inhibit the initiation of
protein synthesis (e.g. removing extracellular calcium) could
have large effects on the permeability of the RER.
Dynamic fluctuations in Pbasal might also occur at a micro-
scopic level as protein synthesis within local regions of the RER
undergoes its normal cyclical course. For example, the perme-
ation of empty RBTs by calcium or other small molecules fol-
lowing the release of a completed protein could produce a
diffusible signal coupled to the end of translation, perhaps
playing a role in stimulating the disassembly and reassembly
of a translationally active RBT with successive cycles of protein
translation. Molecules entering the lumen through an empty
RBT might also signal its availability for the retrograde export
of misfolded proteins through the pore of the RBT (25). At a
microscopic level, the opening of RBTs might produce nearly
quantal changes in Pbasal compared with the macroscopic
changes in Pbasal averaged over larger dimensions. For exam-
ple, the opening of an RBT could produce a rapid and large
change in the local concentrations of molecules within the
lumen of the RER, given the very small volume of the lumen
and the potentially large flux of molecules through an empty
RBT.
In conclusion, the permeability of the RER to small mole-
cules should be viewed as a dynamic property influenced by
protein translation. We propose that dynamic coupling could
occur in any cells in which empty ribosomes remain bound to
translocons following the completion of translation. Recogni-
tion of the dynamic nature of this relationship provides new
insight into the generation of novel signals and the potential
loss of homeostatic regulation under pathophysiological
conditions.
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